Robert Califf, FDA commissioner (AP images)
FDA settles drug compounding suit, agrees to speed its review of bulk ingredients
Back in 2014, the FDA made very clear to the growing but under-regulated pharma compounding world that it would begin implementing a new law from …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
